Sangamo Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and a Favorable Safety Profile

Patient Stories

Fabry Disease Stories


Hemophilia A Stories


Prion Stories


Renal Transplant Stories